John Castellano
Analyst · Prospector Partners
Thanks, Steve. Good morning and thank you for joining us today. Much has changed since our last call with the financial community. As you know, we commenced proceedings under Chapter 11 in March of this year and emergence September 30. Earlier today, we reported results for the third quarter that included significant adjustments to balance sheet items that also affected our income statement. John Barpoulis will cover our financial results in a few minutes; and Tracy Mey, our Chief Accounting Officer, will also provide a short primer on fresh start accounting. Later today, we expect to file our Quarterly Report on Form 10-Q with the SEC, and that document has significant additional detail on the accounting adjustments. I joined the Centrus management team last October as the Chief Restructuring Officer. The position I’ve held with other energy and infrastructure related companies that were engaged with AlixPartners. My firm has an extensive practice involving energy companies and I have been involved with a range of large, complex restructurings since I’ve joined the firm in 1998. Although, Centrus in unique in the United States as a publically traded supplier of nuclear fuel, many of the core issues involving capital structure, supply and demand, and appropriate development spending are not unique and fit within my professional experiences. I deeply appreciate the Board’s confidence in selecting me for this interim leadership role. Given that I spent the past year with this management team, we’ve been able to hit the ground running following emergence from Chapter 11. Today, Centrus is in a much better condition financially than where we were 12 months ago. With that said, we have many things on our plate; I would like to hit the highlights of what is ahead for the Centrus management team over the next several months. First, we are working with the top executive recruitment firm, Spencer Stuart, to help us identify and select our next Chief Executive Officer. We are considering both internal and external candidates. This is obviously a very important selection for Centrus and the Board of Directors is committed to spending the time and diligence necessary to find a vibrant and energetic leader, who will be able to successfully lead the company through this period of transition. We hope to complete the process in early 2015. In the meantime, our work is not on hold. In October, we completed the return of the Paducah plant to the Department of Energy, a project begun in June 2013. This is a significant task, as the Gaseous Diffusion Plant in Kentucky is among the largest industrial sites in the United States with approximately 150 acres of floor space. The task of preparing the Paducah plant for return to DOE required detailed plan and flawless execution. Our people relocated uranium inventory to other approved storage facilities and sold surplus equipment during a serious of auctions in recent months. This transition was completed in a cost-efficient and collaborative manner with DOE. We are very proud of the professional manner in which our employees safely completed the turnover of the Paducah plant to DOE. And although, nearly all of our remaining Paducah employees were terminated at the end of the process, many were hired by the DOE contractor that will complete the decontamination and decommissioning of the facility. Turning next to our common stock. In April 2013, our total market capitalization did not meet the continued listing standards of the New York Stock Exchange. We prepared a plant to regain compliance, and over the past several quarters, we executed that plan, which of course included the Chapter 11 process. Our new common stock, which trades under the ticker LEU is now back in compliance with the exchange’s continued listing standards, after trading above and average market capitalization of $50 million over a 30-day trading period. In addition, the stockholders equity on the Centrus balance sheet was $59 million at September 30, further strengthening our compliance with the exchange’s continued listing standards. Moving to the nuclear fuel market, last week Kagoshima became the first Japanese prefecture to give its consent for the restart of nuclear reactors following the terrible aftermath of the earthquake and tsunami that struck Japan in March of 2011. As part that process that involved many months of careful review and new industry safety regulations, the assembly and governor of Kagoshima provided the necessary local approvals for the restart of two reactors at the Sendai nuclear plant. There are few more steps to the process, but many observers believe the reactors at Sendai will restart in early 2015 and 18 more Japanese reactors are in the regulatory review queue. This is clearly a good a sign for our industry and the psychological effect on the market can already be seen in the price of natural uranium, which has moved back above $40 recently. Just as clearly, however, there is still a very long way to go in rebuilding confidence in the nuclear power industry in Japan. The restart of Japanese reactors will likely have a positive impact on the nuclear fuel market. A recovery of the nuclear fuel industry is essential to our long-term plan to build a commercial plant using the American Centrifuge technology. We are continuing to perform work and demonstrate the technology through the America Centrifuge Technology Demonstration and Operation Agreement, which we refer to as ACTDO agreement. Under this agreement, we are working closely with the Oak Ridge National Laboratory, to continue operations of the Centrifuge cascade and perform additional development while preserving the option of commercial deployment. The laboratory has exercised its first option to extend the program in March 31, 2015 and has the option to extend the program further to the end of September 2015. We believe there is a strong recognition that the United States needs a domestic source of uranium enrichment for both national security and energy security, and that the American Centrifuge is the only enrichment technology when you step into that role. I’d also like to add, having worked with Centrus for over 12 months, I’ve had the opportunity to understand and appreciate the enormous task this company and its employees underwent to develop and demonstrate the American Centrifuge. Our employees are among the worlds leading experts in centrifuge technology and are completely dedicated to the continued development and deployment of this technology. As investors, you should feel very confident that you have the best in the business working at Centrus. The other major item on our front burner is to continue our core business of selling low enriched uranium. Until a new commercial plant is deployed, we will make sales from our inventory, LEU obtained from Russia and from other potential suppliers. The transition also involves streamlining our management processes and sizing our organization to better match our business model. In summary, it has been a very busy and productive 12 months. In the past year, we completed negotiations with the majority of our noteholders about restructuring the debt, which allowed us to go through a pre-arranged and consensual Chapter 11 process in seven months. We were gratified to see the overwhelming support we received from our investor for our plan of reorganization. We have significantly reduced our leverage and cash interest burden. We believe Centrus has emerged with a stronger financial base from which to move forward as a sponsor of the American Centrifuge Technology and a trusted supplier of LEU. We have returned the Paducah plant to DOE. We are actively engaged with the Oak Ridge National Laboratory to further demonstrate the American Centrifuge Technology’s ability to meet our nation’s energy and national security requirements. And we are, once again, in full compliance with the listing standards of the New York Stock Exchange. That’s a good start, but we recognize that we still have much to accomplish. Now, I’d like to turn the call over to John Barpoulis and Tracy Mey to provide a high level overview of third quarter results and the application of fresh start accounting. John?